Stockscreener 앱 받기
2.29
2.97%
-0.07
시간 외 거래:
2.29
Traws Pharma Inc 주식(TRAW)의 최신 뉴스
Traws Pharma (NASDAQ:TRAW) Upgraded at Zacks Research - Defense World
HC Wainwright Estimates Traws Pharma FY2025 Earnings - Defense World
Traws Pharma (NASDAQ:TRAW) Cut to “Sell” at Wall Street Zen - Defense World
HC Wainwright Estimates Traws Pharma Q4 Earnings - Defense World
Can Traws Pharma Inc. (0T20) stock sustain institutional flowsTrade Risk Assessment & Consistent Growth Equity Picks - Newser
What earnings margins imply for Traws Pharma Inc. (0T20) stock2025 Pullback Review & Scalable Portfolio Growth Methods - Newser
HC Wainwright Begins Coverage on Traws Pharma (NASDAQ:TRAW) - Defense World
Is Traws Pharma Inc. stock trading near support levelsTrade Performance Summary & AI Powered Buy/Sell Recommendations - Newser
How Traws Pharma Inc. (0T20) stock behaves under inflation pressureJuly 2025 Outlook & Precise Trade Entry Recommendations - Newser
Will Traws Pharma Inc. (0T20) stock benefit from sector leadership2025 Pullback Review & AI Forecasted Entry/Exit Points - Newser
Why ETFs are accumulating Traws Pharma Inc. (0T20) stockQuarterly Earnings Report & Entry and Exit Point Strategies - Newser
Is Traws Pharma Inc. (0T20) stock positioned for secular growthWeekly Loss Report & Weekly High Return Stock Forecasts - Newser
Is Traws Pharma Inc. (0T20) stock prepared for digital transition2025 Market WrapUp & Stepwise Trade Signal Guides - Newser
HC Wainwright & Co. Initiates Coverage of Traws Pharma (TRAW) with Buy Recommendation - Nasdaq
This Linde Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday - Benzinga
Traws Pharma (TRAW) Receives Buy Rating from HC Wainwright & Co. - GuruFocus
Is Traws Pharma Inc. stock a safe buy before earnings2025 Stock Rankings & Growth Oriented Trading Recommendations - Newser
Will Traws Pharma Inc. (0T20) stock recover faster than industry - Newser
Traws Pharma shareholders approve incentive plan changes and elect directors - Investing.com Nigeria
Traws Pharma Begins Phase 2 Trial of Ritonavir-Free COVID-19 Treatment Ratutrelvir - MSN
[Form 4] Traws Pharma, Inc. Insider Trading Activity - Stock Titan
Traws Pharma Inc (TRAW) Clearly Signals Buy-Into the Stock: Don’t ignore the signals - Setenews
Traws Pharma’s TRX-100 Study: A Potential Game-Changer in Pharmacokinetics - MSN
Is Traws Pharma Inc. stock a defensive play in 2025Rate Cut & Consistent Return Strategy Ideas - newser.com
Is Traws Pharma Inc. (0T20) stock testing key supportCEO Change & Safe Capital Investment Plans - newser.com
Why Traws Pharma Inc. (0T20) stock could be next leaderMarket Activity Summary & Fast Moving Market Watchlists - newser.com
How Traws Pharma Inc. stock reacts to inflationary pressuresLong Setup & Consistent Growth Stock Picks - newser.com
Is Traws Pharma Inc. stock a contrarian buyCEO Change & Consistent Profit Trade Alerts - newser.com
Is a relief rally coming for Traws Pharma Inc. holdersRate Hike & Safe Capital Growth Trade Ideas - newser.com
Traws Pharma, Inc. (TRAW) stock price, news, quote and history - Yahoo Finance UK
Traws Pharma Pushes Ahead on COVID and Flu Antivirals as Costs Fall and Pipeline Advances - MyChesCo
How Traws Pharma Inc. (0T20) stock trades pre earningsWeekly Gains Summary & Long-Term Capital Growth Ideas - newser.com
Price action breakdown for Traws Pharma Inc.2025 Market Overview & Low Drawdown Momentum Ideas - newser.com
1.44%
0.91%
자본화:
|
볼륨(24시간):